Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Map Syndrome”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableEnded earlyNCT03582046
What this trial is testing

Targeting Abdominal Perfusion Pressure in Septic Shock

Who this might be right for
Acute Kidney InjurySeptic ShockResuscitations
Potrero Medical 12
Post-approval studies (Phase 4)UnknownNCT02489864
What this trial is testing

The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure

Who this might be right for
Hepatorenal Syndrome
Sun Yat-sen University 30
Not applicableStudy completedNCT01443494
What this trial is testing

High MAP in Septic Shock With Hypertension

Who this might be right for
Septic Shock
Southeast University, China 19
Not applicableStudy completedNCT02198092
What this trial is testing

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Who this might be right for
Familial Adenomatous PolyposisMap SyndromeLynch Syndrome+2 more
University of Pennsylvania 24
Post-approval studies (Phase 4)Study completedNCT02519699
What this trial is testing

Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension

Who this might be right for
Septic Shock
Federal University of São Paulo 40
Large-scale testing (Phase 3)Looking for participantsNCT07498426
What this trial is testing

Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals 300
Not applicableNo Longer AvailableNCT04476706
What this trial is testing

Canakinumab MAP in COVID-19 Pneumonia With CRS

Who this might be right for
Cytokine Release Syndrome in COVID-19-induced Pneumonia
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02145468
What this trial is testing

Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Who this might be right for
Acute Coronary Syndrome
GlaxoSmithKline 3,503
Not applicableLooking for participantsNCT07383220
What this trial is testing

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

Who this might be right for
Resistant HypertensionHemodynamic InstabilityEssential (Primary) Hypertension+5 more
Mohamed Mohamed Ali Morgan 50
Not applicableLooking for participantsNCT07572942
What this trial is testing

Laser-Based Map Tests in Motoric Cognitive Risk Syndrome

Who this might be right for
Motoric Cognitive Risk SyndromeCognitive-Motor InteractionSensorimotor Performance
Balikesir University 35
Not applicableStudy completedNCT03824366
What this trial is testing

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy

Who this might be right for
MalignancyMetastasisHemoptysis+4 more
Washington University School of Medicine 20
Not applicableUnknownNCT04136080
What this trial is testing

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Who this might be right for
Septic Shock
Fujian Provincial Hospital 752
Not applicableStudy completedNCT01752296
What this trial is testing

Psychological Concomitants of Morquio Syndrome (The MAP Study)

Who this might be right for
Morquio DiseaseMucopolysaccharidosis IV
Nadia Ali, PhD 20
Not applicableEnded earlyNCT01473498
What this trial is testing

Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock

Who this might be right for
Septic ShockAcute Kidney Injury
Assistance Publique - Hôpitaux de Paris 27
Not applicableLooking for participantsNCT07015203
What this trial is testing

The Combined First Trimester Screening

Who this might be right for
Preeclampsia (PE)Fetal Growth RestrictionCongenital Abnormalities+4 more
Institute of Health Information and Statistics of the Czech Republic 2,000
Not applicableStudy completedNCT00001642
What this trial is testing

Positional Cloning of the Gene(s) Responsible for Alagille Syndrome

Who this might be right for
Alagille Syndrome
National Human Genome Research Institute (NHGRI) 225
Not applicableAvailableNCT05028166
What this trial is testing

Individual Patient Compassionate Use of Mirdametinib

Who this might be right for
Neurofibromatosis Type 1-Associated Plexiform NeurofibromasHistiocytic NeoplasmOther MAP-K Pathway Driven Diseases
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Not applicableNo Longer AvailableNCT04498871
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With HES

Who this might be right for
Hypereosinophilic Syndrome (HES)
Novartis Pharmaceuticals
Not applicableEnrolling By InvitationNCT06758193
What this trial is testing

Validity and Reliability of the MAP-Hand Scale in Patients With Carpal Tunnel Syndrome

Who this might be right for
Carpal Tunnel Syndrome (CTS)
Kirsehir Ahi Evran Universitesi 180
Not applicableAvailableNCT07244289
What this trial is testing

Managed Access Programs for VAY736, Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaSjögren's Syndrome
Novartis Pharmaceuticals
Load More Results